Guaifenesin And Dextromethorphan Hydrobromide
NDC Package 51660-073-86
Package Information
Guaifenesin And Dextromethorphan Hydrobromide is •do not crush, chew, or break tablet•take with a full glass of water•this product can be administered without regard for timing of meals•adults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hours•children under 12 years of age: do not use. Marketed by Ohm Laboratories Inc, this product is identified by NDC 51660-073 and is authorized under FDA application NDA021620.
Identification & Billing
- RxCUI: 1099074 - guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet
- RxCUI: 1099074 - 12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet
- RxCUI: 1099074 - dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51660 - Ohm Laboratories Inc
- 51660-073 - Guaifenesin And Dextromethorphan Hydrobromide
- 51660-073-86 - 2 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
- 51660-073 - Guaifenesin And Dextromethorphan Hydrobromide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51660-073). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51660-073-86 identifies a specific commercial package of 2 blister pack in 1 carton / 14 tablet, extended release in 1 blister pack of Guaifenesin And Dextromethorphan Hydrobromide, labeled by Ohm Laboratories Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ohm Laboratories Inc on December 10, 2017. The current certification is valid through December 31, 2023.
How is this Ohm Laboratories Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51660007386. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.